liveBook · Manning

Forced vital capacity

As explained in Build AI Drug Discovery Pipelines

Forced vital capacity is the volume of air that a person can forcibly exhale after taking a maximal breath.

Forced vital capacity (FVC) measures the volume of air a person can forcibly exhale after taking a maximal breath. section 13.3.1

In idiopathic pulmonary fibrosis, FVC serves as a clinical efficacy measure. Changes over time can indicate whether lung function improves or declines during treatment. section 13.3.1

Rentosertib Phase 2a signal

After 12 weeks, patients receiving 60 mg once daily showed a mean FVC improvement of 98.4 mL, compared with a mean decline of 20.3 mL for placebo. The small, short trial made this encouraging but not definitive. section 13.3.1

How Build AI Drug Discovery Pipelines covers it

How deep it goes
Defines FVC and interprets a trial signal, but does not detail measurement procedures or physiological mechanisms.
Examples
Reports 98.4 mL improvement with 60 mg rentosertib versus a 20.3 mL placebo decline at 12 weeks.
What you can do after
Evaluate dose-dependent changes in lung function using FVC as a clinical trial endpoint.
How it connects
Connects FVC with idiopathic pulmonary fibrosis, clinical trials, placebo comparisons, and treatment efficacy.

This explainer was generated by Manning's knowledge graph from the text of Build AI Drug Discovery Pipelines. The section links point to the parts of the book it draws on.